Načítá se...
Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment
BACKGROUND: There are sex differences in buprenorphine/naloxone clinical trials for opioid use. Whereas women have fewer opioid-positive urine samples, relative to men, a significant decrease in opioid-positive samples was found during treatment for men, but not women. In order to inform sex-based a...
Uloženo v:
| Vydáno v: | Am J Drug Alcohol Abuse |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186400/ https://ncbi.nlm.nih.gov/pubmed/29672167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2018.1458234 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|